Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Extension study results evaluating safety and effectiveness of dasotraline in binge-eating disorders

Dec. 24, 2019

FDA approves Dayvigo for insomnia

Dec. 23, 2019

Lack of clinical effect with AVL-3288 in phase Ib trial in schizophrenia patients

Dec. 23, 2019

AC Immune discovers microtubule-associated protein tau aggregation inhibitors

Dec. 20, 2019

Spravato nasal spray approved in Europe

Dec. 20, 2019

Initiation of first-in-human study of ANLE-138b

Dec. 19, 2019

First patients dosed in phase I clinical program of CTI-1601 for treatment of Friedreich's ataxia

Dec. 19, 2019

ALDH2 and Alzheimer's

Dec. 19, 2019

CXCL10 arises as a potential therapeutic target for treating motor neuron disease

Dec. 19, 2019

ARM-210 studied in new clinical trial for ryanodine receptor type 1-related myopathies

Dec. 18, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...